Pharmacoepidemiological aspects of antibacterial therapy of salpingoophoritis in hospital settings
https://doi.org/10.20538/1682-0363-2018-1-149-158
Abstract
The purpose of the study is an analysis of the consumption of antibacterial drugs in the therapy of salpingoophoritis in hospital settings and evaluation of changes in the real clinical practice of antibiotic therapy after the introduction of the “Order of medical care for the profile “obstetrics and gynecology...”.
Materials and methods. In a retrospective study, an assessment was made of the prescriptions of antibacterial drugs in the therapy of salpingoophritis in specialized treatment and prophylactic institutions of the city of Tomsk in the period 2010–2014. The analysis included 160 case histories. The structure of prescriptions was evaluated on the basis of the application of anatomical-therapeutic-chemical classification and international non-proprietary names (INN), the structural improvement factor K. Gatev was calculated. To quantify the consumption of medications, the calculated daily dose (PDD) was used.
Results. Comparative analysis of antibacterial therapy of salpingoophoritis in hospital before and after the introduction of the “Order of medical care for the profile of «obstetrics and gynecology...”. Leading groups of antibacterial drugs were identified. А comparative analysis of the frequency of assignment of various INN was made. The К. Gate’s coefficient was 0.281. The calculation of the average prescribed daily doses of antibacterial drugs was performed.
Conclusion. The review of the consumption of antibacterial drugs for salpingoophoritis therapy in hospital settings before and after the introduction of the “Order of medical care for the profile “obstetrics and gynecology...”, showed that the range of antibacterial drugs used increased from 18 to 24 INN, mainly due to the inclusion of modern medicines. In the structure of appointments in 2013–2014, the proportion of drugs not recommended for use by the «Order of medical care for the profile of «obstetrics and gynecology» was 37.5%. It was found that PDD clarithromycin, clindamycin and cefotaxime did not meet the recommended dosing regimens specified in the clinical recommendations for antibiotic therapy. The gap between actual clinical practice and existing clinical recommendations determines the need for in-depth pharmacoepidemiological evaluation to identify the causes and develop measures of an organizational and educational nature to optimize the use of medications.
About the Authors
E. A. UshkalovaRussian Federation
Ushkalova Elena A., DM, Рrofessor, Department of General and Clinical Pharmacology.
6, Str. Miclukho-Maclai, Moscow, 117198.
L. Yu. Chernikova
Russian Federation
Chernikova Larisa Yu., Senior Lecturer, Department of Surgery with the Сourse of Mobilization Training and Medicine of Catastrophes. 2, Moscow Tract, Tomsk, 634050.
I. D. Evtushenko
Russian Federation
Yevtushenko Irina D., DM, Professor, Head of the Department of Obstetrics and Gynecology.
2, Moscow Tract, Tomsk, 634050.
E. V. Karakulova
Russian Federation
Karakulova Elena V., DFSc, Professor, Basic Сhair of Management and Economics of Pharmacy.
2, Moscow Tract, Tomsk, 634050.
V. A. Fokin
Russian Federation
Fokin Vasiliy A., DТSc, Professor, Department of Medical Biological Cybernetics with a Course in Medical Informatics.
2, Moscow Tract, Tomsk, 634050.
M. V. Belousov
Russian Federation
Belousov Mikhail V., DFSc, Professor, Head of the Department of Pharmaceutical Analysis of the State Public Health Service.
2, Moscow Tract, Tomsk, 634050.
References
1. Utkin E.V. Purulent pelvic inflammatory disease at women: modern features of clinic, diagnostics and therapy. Mat i ditya v Kuzbasse – Mother and Сhild in Kuzbass. 2009; 3 (38): 9–15 (in Russ.).
2. Naumov I.A., Tischenko Ye.M. The medical social stipulation of reproductive behavior of female patients with inflammatory diseases of genitals. Problemy sotsialnoy gigieny, zdravookhraneniya i istorii meditsiny – Problems of Social Hygiene, Health and History of Medicine. 2012; 6: 10–13 (in Russ.).
3. Utkin E.V., Artymuk N.V., Chernyaeva V.I., Zelenina E.M., Khodareva I.V. Clinical protocol. Inflammatory diseases of the pelvic organs in women. StatusPraesens. Ginekologiya, akusherstvo, besplodnyy brak – StatusPraesens. Gynecology, Оbstetrics, Вarren Мarriage. 2016; 3 (32): 144–150 (in Russ.).
4. Order of the Ministry of Health of Russia from 01.11.2012 № 572n “On approval of the order of rendering medical assistance in the field of obstetrics and gynecology (except for the use of assisted reproductive technologies)”. URL: http:// base.consultant.ru (in Russ.).
5. Yurasov I.V., Yurasova E.A. Antimicrobial therapy in inflammatory diseases of female reproductive organs. Dal’nevostochnyy meditsinskiy zhurnal – Far Eastern Medical Journal. 2013; 2 (32): 105–108 (in Russ.).
6. Rafalsky V.V., Dovgan Ye.V., Ivanyan A.N., Sawicky A.N. The practice of using antimicrobial agents in women with inflammatory diseases of the pelvic organs in the Russian Federation. Akusherstvo i ginekologiya – Obstetrics and Gynecology. 2011; 5: 88–93 (in Russ.).
7. Pestrikova T.Y., Yurasov I.V., Yurasova E.A. The consequences of inadequate tactics of antibiotic therapy in patients with inflammatory diseases of the pelvic organs. Vestnik obshchestvennogo zdorovya i zdravookhraneniya Dalnego Vostoka Rossii – Bulletin of Public Health and Health of the Far East of Russia. 2015; 1: URL: http://www.fesmu.ru/voz/20151/2015105.aspx (in Russ.).
8. Persteneva N.P. Сriteria of classification of indicators of structural distinctions and shifts. Fundamentalnye issledovaniya – Fundamental Research. 2012; 3 (2): 478–782 (in Russ.).
9. Introduction to drug utilization research / WHO international working group for drug statistics methodology, WHO collaborating centre for drug statistics methodology, WHO collaborating centre for drug utilization research and clinical pharmacological services. World health organization. 2003: 84.
10. Grjibovski A.M. Confidence intervals for proportions. Ekologiya cheloveka – Human Ecology. 2008; 5: 57–60 (in Russ.).
11. Duarte R. et al. A review of antibiotic therapy for pelvic inflammatory disease. International Journal of Antimicrobial Agents. 2015. URL: http://dx.doi.org/10.1016/j.ijantimicag.2015.05.004.
12. Antibacterial therapy of pelvic inflammatory disease without errors and experiments: a methodical guide for doctors; рod. red. V.E. Radzinsky, R.S. Kozlova, A.O. Dukhina/ M: StatusPraesens Publ., 2013: 16 (in Russ.).
13. Yevstigneev S.V., Alexandrova E.G., Abakumova T.R., Korableva A.A., Titarenko A.F., Khaziakhmetova V.N., Ziganshina L.E.Consumption of antimicrobials at a multidisciplinary hospital: ATC/DDD methodology. Zdorove i obrazovanie v XXI veke – Health and Education Millennium. 2017; 7: 131–137 (in Russ.).
14. Klenina N.M., Rykalina E.B. Pharmacoepidemiological analysis of antimicrobial therapy of salpingoophoritis in hospitals the Saratov region. Byulleten meditsinskikh internet-konferentsiy – Bulletin of Medical Internet Conferences. 2014; 5: 799 (in Russ.).
15. Rostova N.B. The international recommendations and national perspectives of rational application of pharmaceuticals for resolving issues of medicinal support of population. Rossiyskiy meditsinskiy zhurnal – Rossiiskii Meditsinskii Zhurnal. 2015; 2: 40–45 (in Russ.).
16. Practical guidance on anti-infectious chemotherapy; рod. red. Strachunsky L.S.; Belousova Yu.B., Kozlova S.N. Smolensk: MAKMAH Publ., 2007: 464 (in Russ.).
Review
For citations:
Ushkalova E.A., Chernikova L.Yu., Evtushenko I.D., Karakulova E.V., Fokin V.A., Belousov M.V. Pharmacoepidemiological aspects of antibacterial therapy of salpingoophoritis in hospital settings. Bulletin of Siberian Medicine. 2018;17(1):149-158. (In Russ.) https://doi.org/10.20538/1682-0363-2018-1-149-158